Management of chronic hepatitis C in HIV-Co-infected patients - Results from the first international workshop on HIV and hepatitis co-infection

European Journal of Medical Research

Volumn 10, Issue 1, 2005, Pages 43-45

  Tossing, Gudrun ^a  

^a Essex Pharma GmbH   (Germany)

Author keywords

1st International Workshop on HIV and Hepatitis Co infection 2004; Antiretroviral therapy (ART); Chronic hepatitis C (cHC); Epidemiology; HCV; HIV; Liver disease; Pathogenesis; Pegylated interferon alpha (PegIFN alpha); Ribavirin (Rbv); Treatment of chronic hepatitis C; Viral interactions

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; STAVUDINE; VIRUS PROTEIN; ZIDOVUDINE;

ANEMIA; ANTIVIRAL ACTIVITY; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; FIBROSIS; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; LIVER INJURY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MORTALITY; OPPORTUNISTIC INFECTION; PATHOGENESIS; PATIENT COMPLIANCE; RECURRENCE RISK; RELAPSE; RISK FACTOR; SUPERINFECTION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT WITHDRAWAL; VIRUS CELL INTERACTION; VIRUS TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLINICAL MEDICINE; EDUCATION; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; WORLD HEALTH;

EID: 14544267743     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Greub G, Ledergerber B, Battegay M et al. Clinical progression, survival and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection. Lancet 2000; 356: 1800-1805
2. Manns MP, McHutchinson JG, Gordon SC et al. Peginterferon alfa2b in combination with ribavirin compared to interferon alfa2b plus ribavirin for initial treatment of chronic hepatitis C: results of a randomized trial. Lancet 2001; 358: 958-965
3. Chung R, Andersen J, Volberding P, et al. A randomized contolled trial of peg-interferon-alfa2a + ribavirin versus interferon-alfa2a + ribavirin for chronic hepatitis C virus infection in HIV-coinfected persons: follow-up results of ACTG A5071. 11th Conference on Retroviruses and Opportunistic Infections. San Francisco, CA, USA, Feb 8-11, 2004: abstr 110
4. Torriani FJ, Rockstroh J, Rodriguez-Torres M, et al. Final results of APRICOT: a randomized partially blinded international trial evaluating peg-interferon-alfa2a + ribavirin in the treatment of HCV in HIV/HCV coinfection. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, USA, Feb 8-11, 2004: abstract 112
5. Perronne C, Carrat F, Bani-Sadr F, et al. Final results of ANRS HCO2-Ribavic: a randomized controlled trial of pegylated interferon-alfa2b + ribavirin in the treatment of chronic hepatitis C in HIV-coinfected patients. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, USA, Feb 8-11, 2004: abstr 117LB
6. Voigt E., Schulz C, Mauss S, et al. Factors related to outcome of treatment with pegylated interferon-alfa2b (PEG-INF) + ribavirin (RBV) in HCV/HIV-coinfected patients. 2nd IAS Conference on HIV Pathogenesis and Treatment, Paris, France, 2003: abstr 976
7. Perez-Olmeda M, Nunez M, Romero M, et al. Pegylated interferon-alfa2b + ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 2003; 17: 1023-28
8. Moreno L, Quereda C, Moreno A et al. Pegylated interferon-alfa2b + ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. AIDS 2004; 18: 67-73
9. Laguno M, Murrilas J, Blanco JL et al. Pegylated interferon-alfa2b plus ribavirin compared with interferon-alfa2b plus ribavirin for treatment of HIV/HCV coinfected patients. AIDS 2004; 18: F27-F36
10. Soriano V, Sulkowski M, Bergen C et al. Care of patients with chronic hepatitis C and HIV coinfection: recommendations from the HIV/HCV International Panel. AIDS 2002; 16: 813-24
11. Soriano V, Puoti M, Sulkowski M et al. Care of patients with hepatitis C and HIV-coinfection. AIDS 2004; 18: 1-12